Reuters Market Eye - The BSE Sensex gains more than 100 points, rebounding after falling for two consecutive sessions. The BSE Sensex was trading up 134 points while the Nifty gained 40 points at 2.12 pm.
Bank shares, which were among the leading decliners, lead gains: Axis Bank is up 0.39 percent, while ICICI Bank Ltd gains 0.18 percent.
IDFC , a contender for a banking license by India's central bank, gains 2.18 percent after salt-to-software conglomerate Tata Sons withdrew its application for an Indian banking license, dealers say.
Tata's withdrawal could increase chances of IDFC obtaining a banking license, the traders add.
Dr Reddy's Laboratories Ltd shares gain 1.09 percent on hopes of increased in its market share of a key anti-hypertension generic drug Toprol after a second plant operated by its competitor Wockhardt Ltd was hit by the U.S. Food and Drug Administration's "import alert".
(Reporting by Abhishek Vishnoi)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
